NCT07596212 BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07589699 Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP Status NOT_YET_RECRUITING Phase PHASE4
NCT07483996 Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07366112 CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment Status RECRUITING Phase PHASE2
NCT07215364 Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors Status RECRUITING Phase NA
NCT07178665 Pilot Trial of Preop Partial Radiation in Breast Cancer Patients Status SUSPENDED Phase PHASE1
NCT06970912 ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06902311 Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) Status RECRUITING Phase PHASE2
NCT06650748 Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06536881 Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming Status RECRUITING Phase NA
NCT06446882 Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer Status RECRUITING Phase NA
NCT06409221 VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study Status ENROLLING_BY_INVITATION Phase N/A
NCT06295744 Outcomes and Cosmesis With Whole Breast Irradiation and Boost Status ACTIVE_NOT_RECRUITING Phase NA
NCT06215469 Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) Status ACTIVE_NOT_RECRUITING Phase NA
NCT06152471 Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer Status RECRUITING Phase PHASE3
NCT06150898 Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) Status RECRUITING Phase PHASE2
NCT06144944 Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06052345 Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes Status WITHDRAWN Phase N/A
NCT06035016 Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer Status RECRUITING Phase N/A